Abstract:BACKGROUND:Genome-wide association studies (GWAS) have successfully identified genetic susceptible variants for complex diseases. However, the underlying mechanism of such association remains largely unknown. Most disease-associated genetic variants have been shown to reside in noncoding regions, leading to the hypothesis that regulation of gene expression may be the primary biological mechanism. Current methods to characterize gene expression mediating the effect of genetic variant on diseases, often analyzed one gene at a time and ignored the network structure. The impact of genetic variant can propagate to other genes along the links in the network, then to the final disease. There could be multiple pathways from the genetic variant to the final disease, with each having the chain structure since the first node is one specific SNP (Single Nucleotide Polymorphism) variant and the end is disease outcome. One key but inadequately addressed question is how to measure the between-node connection strength and rank the effects of such chain-type pathways, which can provide statistical evidence to give the priority of some pathways for potential drug development in a cost-effective manner.RESULTS:We first introduce the maximal correlation coefficient (MCC) to represent the between-node connection, and then integrate MCC with K shortest paths algorithm to rank and identify the potential pathways from genetic variant to disease. The pathway importance score (PIS) was further provided to quantify the importance of each pathway. We termed this method as "MCC-SP". Various simulations are conducted to illustrate MCC is a better measurement of the between-node connection strength than other quantities including Pearson correlation, Spearman correlation, distance correlation, mutual information, and maximal information coefficient. Finally, we applied MCC-SP to analyze one real dataset from the Religious Orders Study and the Memory and Aging Project, and successfully detected 2 typical pathways from APOE genotype to Alzheimer's disease (AD) through gene expression enriched in Alzheimer's disease pathway.CONCLUSIONS:MCC-SP has powerful and robust performance in identifying the pathway(s) from the genetic variant to the disease. The source code of MCC-SP is freely available at GitHub ( https://github.com/zhuyuchen95/ADnet ).

A comprehensive framework for trans-ancestry pathway analysis using GWAS summary data from diverse populations

MCC-SP: a Powerful Integration Method for Identification of Causal Pathways from Genetic Variants to Complex Disease.

Identifying Disease Related Sub-Pathways for Analysis of Genome-Wide Association Studies

Improving the detection of pathways in genome-wide association studies by combined effects of SNPs from Linkage Disequilibrium blocks

Pathway-wide Association Study Identifies Five Shared Pathways Associated with Schizophrenia in Three Ancestral Distinct Populations

Integration of Enhancer-Promoter Interactions with GWAS Summary Results Identifies Novel Schizophrenia-Associated Genes and Pathways

Network-Based Analysis Of Schizophrenia Genome-Wide Association Data To Detect The Joint Functional Association Signals

Gene and Pathway-Based Analysis: Second Wave of Genome-wide Association Studies

Pathway Analysis of Complex Diseases for GWAS, Extending to Consider Rare Variants, Multi-Omics and Interactions

Strategies for Pathway Analysis from GWAS Data

Brain eQTLs of European, African American, and Asian ancestry improve interpretation of schizophrenia GWAS

Gene and Pathway-Based Second-Wave Analysis of Genome-Wide Association Studies

Integrating genome-wide association study with regulatory SNP annotation information identified candidate genes and pathways for schizophrenia.

Strategies for Pathway Analysis Using GWAS and WGS Data

Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data

A statistical method for region-based meta-analysis of genome-wide association studies in genetically diverse populations

Cross-ancestry analysis of brain QTLs enhances interpretation of schizophrenia genome-wide association studies

A statistical framework for GWAS of high dimensional phenotypes using summary statistics, with application to metabolite GWAS

Pathways-Driven Sparse Regression Identifies Pathways and Genes Associated with High-Density Lipoprotein Cholesterol in Two Asian Cohorts

Protein-interaction-network-based analysis for genome-wide association analysis of schizophrenia in Han Chinese population

Beyond guilty by association at scale: searching for causal variants on the basis of genome-wide summary statistics